“It’s time to reorient the mindset around Pharmaceutical Benefits Scheme reimbursement. Australians with a clear medical need should not miss out on access to an innovative medicine with proven clinical benefit because the patient pool is considered too large to allow for Government funding,” said Eli Lilly general manager Tori Brown. …
'A procurement mindset must not impede equitable access to medicines that offer significant benefits'
November 14, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
NSW pharmacists to deliver all childhood vaccines and treat more conditions under reforms
September 11, 2026 - - Latest News -
Rare genetic motor neurone disease treatment finally reaches Australian patients
September 11, 2026 - - Latest News -
Taking a stake is not the same as spectating investor risk and expecting a benefit
September 10, 2026 - - Latest News -
Artificial intelligence in HTA has arrived, kind of, but nobody was thinking of this
September 10, 2026 - - Latest News -
Melbourne oncologist takes the reins at Australia's private cancer physicians body
September 10, 2026 - -
Australia secures sovereign viral vector manufacturing as VVMF wins TGA licence
September 10, 2026 - - Latest News -
Which is it? The two perspectives on patient input compounded by the lack of transparency
September 10, 2026 - - Latest News